Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
Sponsor: Zealand Pharma
Summary
The primary objective of the trial is to evaluate the long-term safety of glepaglutide treatment in patients with short bowel syndrome (SBS). Glepaglutide is the International Nonproprietary Name and USAN for ZP1848.
Official title: A Double-Blind Phase 3 Extension Trial Assessing the Long Term Safety and Efficacy of Glepaglutide in Patients With Short Bowel Syndrome (SBS)
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
145
Start Date
2019-05-07
Completion Date
2026-04
Last Updated
2026-01-30
Healthy Volunteers
No
Conditions
Interventions
glepaglutide
Glucagon-Like Peptide-2 (GLP-2) analog
Locations (27)
Georgetown University Medical Center
Washington D.C., District of Columbia, United States
University of Chicago Children's Hospital
Chicago, Illinois, United States
Mayo Clinic College of Medicine
Rochester, Minnesota, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Mount Sinai Hospital
New York, New York, United States
Cleveland Clinic
Cleveland, Ohio, United States
Vanderbilt University Medical Center, Nashville
Nashville, Tennessee, United States
UZ Leuven
Leuven, Belgium
The Royal Alexandra Hospital
Edmonton, Canada
Western University
London, Canada
University Health Network - Toronto General Hospital
Toronto, Canada
Rigshospitalet
Copenhagen, Denmark
Hôpital Beaujon
Clichy, France
Centre Hospitalier Lyon-Sud
Pierre-Bénite, France
Charité - Universitätsmedizin Berlin
Berlin, Germany
Universitätsklinikum Bonn
Bonn, Germany
Universitätsklinikum Frankfurt - Med. Klinik I
Frankfurt, Germany
Asklepios Kliniken Hamburg GmbH
Hamburg, Germany
Universitätsmedizin Rostock
Rostock, Germany
UMC Radboud Nijmegen
Nijmegen, Netherlands
Wojewodzki Specjalistyczny Szpital im. M. Pirogowa w Lodzi
Lodz, Poland
Solumed
Poznan, Poland
Szpital Skawina sp. z o.o. im. Stanley Dudricka
Skawina, Poland
St Mark's Hospital
Harrow, United Kingdom
UCLH Foundation NHS Trust
London, United Kingdom
University of East Anglia
Norwich, United Kingdom
University Hospital Southampton NHS Foundation Trust
Southampton, United Kingdom